Addressing the spread of coronavirus disease 2019 (COVID-19)
has
highlighted the need for rapid, accurate, and low-cost diagnostic
methods that detect specific antigens for SARS-CoV-2 infection. Tests
for COVID-19 are based on reverse transcription PCR (RT-PCR), which
requires laboratory services and is time-consuming. Here, by targeting
the SARS-CoV-2 spike protein, we present a point-of-care SERS detection
platform that specifically detects SARS-CoV-2 antigen in one step
by captureing substrates and detection probes based on aptamer-specific
recognition. Using the pseudovirus, without any pretreatment, the
SARS-CoV-2 virus and its variants were detected by a handheld Raman
spectrometer within 5 min. The limit of detection (LoD) for the pseudovirus
was 124 TU μL
–1
(18 fM spike protein), with
a linear range of 250–10,000 TU μL
–1
. Moreover, this assay can specifically recognize the SARS-CoV-2
antigen without cross reacting with specific antigens of other coronaviruses
or influenza A. Therefore, the platform has great potential for application
in rapid point-of-care diagnostic assays for SARS-CoV-2.